Cara Therapeutics, Inc. (CARA)
15.96
-0.69 (-4.14%)
Inactive · Last trade price
on Apr 15, 2025
Cara Therapeutics Employees
Cara Therapeutics had 10 employees as of December 31, 2024. The number of employees decreased by 45 or -81.82% compared to the previous year.
Employees
10
Change (1Y)
-45
Growth (1Y)
-81.82%
Revenue / Employee
$713,700
Profits / Employee
-$7,086,700
Market Cap
24.33M
Employees Chart
CARA News
- 6 days ago - Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics - GlobeNewsWire
- 7 days ago - Cara Therapeutics Announces 1-for-3 Reverse Stock Split in Connection with the Proposed Merger with Tvardi Therapeutics - GlobeNewsWire
- 2 months ago - CARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cara Therapeutics, Inc. - CARA - Business Wire
- 4 months ago - Cara Therapeutics Announces Effective Date of 1-for-12 Reverse Stock Split - GlobeNewsWire
- 4 months ago - Cara Therapeutics and Tvardi Therapeutics Announce Entry into Merger Agreement - GlobeNewsWire
- 11 months ago - These Cara Therapeutics Analysts Are No Longer Bullish: 'We See No Obvious Future Value Drivers' - Benzinga
- 11 months ago - Cara Therapeutics discontinues study on a neurological condition as drug fails - Reuters
- 11 months ago - Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica - GlobeNewsWire